Guest guest Posted April 7, 2011 Report Share Posted April 7, 2011 News 8 new results for hepatitis c 2 Biotechs Leading the Fight Against Hepatitis CBarron'sDrug makers have been laboring for years to develop new treatments for hepatitis C, an infectious disease which afflicts at least four times as many people worldwide as the virus that causes AIDS. All that effort is paying off for patients and drug ...See all stories on this topic » ROCHE : Joins in Spanish Research ation for Personalized Treatment of ...4-traders (press release)Hepatitis C (HCV) infection affects 3% of the world population, representing a chronic disease for nearly 180 million people. Many infected individuals acquire the disease 15-25 years before identification of the virus and the use of diagnostic tests. ...See all stories on this topic » Merck, J & J's New Hepatitis C Treatments Fetch $31000 in FranceTheBody.comThough they are still under review by the European Medicines Agency, two new hepatitis C virus (HCV) treatments are already being prescribed to French patients. In December, telaprevir and boceprevir received special temporary authorization in a ...See all stories on this topic » Inhibitex To Sell Shares To Public In Stock OfferingWall Street JournalInhibitex said it plans to use the proceeds from the offering for working capital and general purposes, including for its Phase 2 trial for a treatment of chronic hepatitis C infections as well as research-and-development expenses related to other ...See all stories on this topic » Long-Term Consistent Use of HIV Therapy Protects the LiverAIDSmeds.com HIV/AIDS Treatment NewsWhile the vast majority of people with HIV who have liver disease are also infected with either hepatitis C virus (HCV) or hepatitis B virus (HBV), people with HIV who don't have hepatitis are also at significantly increased risk for liver failure. ...See all stories on this topic » Quadruple HCV therapy effective for nonrespondersClinical AdvisorTwo direct-acting antivirals against hepatitis C virus (HCV) currently in development improved virologic responses among patients with HCV when administered alone or in combination with pegylated interferon-alpha-2a (pegIFN-alpha-2a) and ribavirin, ...See all stories on this topic » AACR: Liver Cancer Risk Rises With Metabolic SyndromeMedPage TodayNote that metabolic syndrome remained an independent risk factor for primary liver cancer after controlling for other known risk factors, such as alcoholic liver disease and hepatitis C or B virus infection. ORLANDO -- Metabolic syndrome doubled the ...See all stories on this topic » International conference highlights drug abuse, dealing in RoumiehDaily Star - LebanonA nurse working at the rehabilitation center said the center received prisoners who are tested positive for HIV/AIDS or Hepatitis, and that admitting convicts who are tested positive for Hepatitis C into the prison, doubles the possibility of the ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.